| Oct 23 |
Calidi Biotherapeutics stock tumbles on $2M securities offering
|
| Oct 23 |
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
|
| Oct 21 |
Calidi Biotherapeutics warrants delist from NYSE
|
| Oct 19 |
Calidi Biotherapeutics Faces Warrant Delisting by NYSE
|
| Oct 19 |
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
|
| Oct 18 |
Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
| Oct 1 |
Calidi Biotherapeutics files $25M mixed securities shelf
|
| Sep 30 |
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
|
| Aug 14 |
Calidi Biotherapeutics GAAP EPS of -$1.40
|
| Aug 13 |
Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
|
